Skip to main content
. Author manuscript; available in PMC: 2022 May 19.
Published in final edited form as: Pharmacotherapy. 2022 Feb 21;42(4):298–310. doi: 10.1002/phar.2669

FIGURE 5.

FIGURE 5

Ketamine () and nor-ketamine () average pharmacokinetic concentration versus time profiles after administration via intravenous (IV, 10 mg) or intranasal (IN, 10, 30, or 50 mg) route. Numbers indicate number of informed values (i.e., not imputed as half the lower assay limit: 10 ng/ml) underlying the depicted averages, see methods for further detail